United States · FDA National Drug Code directory
Gabapentin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50268-325_2b4c1c97-dc71-3801-e063-6394a90a7faf
- Product NDC
- 50268-325
- Form
- TABLET, COATED
- Composition / generic term
- Gabapentin
- Labeler
- AvPAK
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230501
- Source listing expiry
- 20261231
Source-listed ingredients
- GABAPENTIN — 600 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 50 BLISTER PACK in 1 BOX (50268-325-15) / 1 TABLET, COATED in 1 BLISTER PACK (50268-325-11) · 50268-325-15
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →